Crossmark

Cognitive-behavioral and mindfulness-based cognitive therapies for adults with attention-deficit/hyperactivity disorder and cognitive disengagement syndrome: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s43045-026-00669-4

Published Online: 2026-09-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kamran, Leila https://orcid.org/0000-0003-3585-4586
Golestaneh, Seyed Mousa https://orcid.org/0000-0002-2828-1030
Pakizeh, Ali https://orcid.org/0000-0002-9522-2276
Rajabi, Sooran https://orcid.org/0000-0002-5025-4549
License Information

Text and Data Mining valid from 2026-09-07

Version of Record valid from 2026-09-07
More Information

Article History

Received: 29 June 2026

Accepted: 18 August 2026

First Online: 7 September 2026

Declarations

Ethics approval and consent to participate: The study protocol was approved by the Ethics Committee of Bushehr University of Medical Sciences (IR.BPUMS.REC.1404.255). The trial was registered in the Iranian Registry of Clinical Trials (IRCT; Registration No. IRCT20250927067383N1). All participants received information about the aims and procedures of the study and provided written informed consent before participation. Participants were informed that their participation was voluntary, their data would remain confidential, and they could withdraw from the study at any time without penalty.

Consent for publication: Not applicable. The manuscript does not contain any individual person’s identifiable data, images, or personal details.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below